297 related articles for article (PubMed ID: 30600646)
1. Tumor-infiltrating CD8
Shimizu S; Hiratsuka H; Koike K; Tsuchihashi K; Sonoda T; Ogi K; Miyakawa A; Kobayashi J; Kaneko T; Igarashi T; Hasegawa T; Miyazaki A
Cancer Med; 2019 Jan; 8(1):80-93. PubMed ID: 30600646
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
3. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
[TBL] [Abstract][Full Text] [Related]
4. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of CD45Ro
Koike K; Nishiyama K; Dehari H; Ogi K; Sasaki T; Shimizu S; Sasaya T; Tsuchihashi K; Sonoda T; Hasegawa T; Hiratsuka H; Miyazaki A
Anticancer Res; 2021 Sep; 41(9):4515-4522. PubMed ID: 34475077
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
[TBL] [Abstract][Full Text] [Related]
10. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL
J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957
[TBL] [Abstract][Full Text] [Related]
12. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129
[TBL] [Abstract][Full Text] [Related]
13. Metavariables Resuming Host Immune Features and Nodal Involvement Are Associated with Oncological Outcomes in Oral Cavity Squamous Cell Carcinoma.
Missale F; Bugatti M; Mattavelli D; Lonardi S; Lombardi D; Nicolai P; Piazza C; Battocchio S; Bozzola AM; Calza S; Vermi W
Cells; 2021 Aug; 10(9):. PubMed ID: 34571850
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
Koike K; Dehari H; Ogi K; Shimizu S; Nishiyama K; Sonoda T; Sasaki T; Sasaya T; Tsuchihashi K; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
PLoS One; 2020; 15(8):e0237465. PubMed ID: 32785290
[TBL] [Abstract][Full Text] [Related]
15. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.
Koike K; Dehari H; Shimizu S; Nishiyama K; Sonoda T; Ogi K; Kobayashi J; Sasaki T; Sasaya T; Tsuchihashi K; Tsukahara T; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
Cancer Sci; 2020 May; 111(5):1491-1499. PubMed ID: 32167621
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Książek M; Lewandowski B; Brodowski R; Pakla P; Kawalec-Książek M; Fudali L; Ryś J
Pol J Pathol; 2019; 70(4):277-285. PubMed ID: 32146797
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
